- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Cardiovascular Psychiatry and Neurology
Volume 2011 (2011), Article ID 315068, 6 pages
Validation of the Turkish Version of the Problem Areas in Diabetes Scale
1Department of Medical Psychology and Neuropsychology, Center of Research on Psychology in Somatic Diseases [CoRPS], Tilburg University, P.O. Box 90153, 5000 LE Tilburg, The Netherlands
2School of Psychology, University of Birmingham, Birmingham B15 2TT, UK
3Bakirkoy Mental and Neurological Disease Hospital, 34147 Bakırköy, Istanbul, Turkey
4Cerrahpasa Medical Faculty, Istanbul University, 34098 Fatih, Istanbul, Turkey
5Istanbul Medical Faculty, Istanbul University, 34452 Beyazit, Istanbul, Turkey
Received 25 July 2011; Accepted 11 October 2011
Academic Editor: Richard C. Veith
Copyright © 2011 Elisabeth M. J. Huis In ‘T Veld et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Problem Areas in Diabetes (PAID) scale is a widely used self-report measure that can facilitate detection of diabetes-specific emotional distress in clinical practice. The aim of this study was to assess the factor structure and validity of the Turkish version of the PAID. A validation study was conducted among 154 patients with insulin-naïve type 2 diabetes. Participants completed the PAID, Centre for Epidemiological Studies Depression Scale (CES-D), Insulin Treatment Appraisal Scale (ITAS), and World Health Organization-Five Well-Being Index (WHO-5) questionnaires. Exploratory factor analyses yielded a 2-factor structure, identifying a 15-item “diabetes distress” factor and a 5-item “support-related issues” factor. The total PAID-score and the two dimensions were associated with higher levels of depression and poor emotional well-being. In the present study, the Turkish version of the PAID had satisfactory psychometric properties, however, the factorial structure was found to differ from factor solutions from other countries.
Type 2 diabetes is an increasingly common, often burdensome illness. People living with type 2 diabetes not only have a chronic condition to cope with, but they are also faced with the presence and/or the prospect of serious complications . The fact that living with diabetes often confronts patients with diabetes-specific stressors may explain the recent findings of Ali et al. , who found that depression is up to four times more likely in patients with type 2 diabetes compared to a general population. In depressed diabetes patients, increased levels of diabetes-specific emotional distress were found [3, 4]. Furthermore, diabetes-specific stressors were found to be associated with less adequate self-care and impaired glycemic control [5, 6]. However, the recognition rates of high levels of diabetes-specific emotional distress appeared to be low . Therefore, it seems important that diabetes health care providers and diabetes researchers have access to instruments that can assess disease-specific emotional distress in a valid and reliable way. One widely used instrument is the Problem Areas in Diabetes (PAID) scale. The PAID is a 20-item self-report survey that assesses a range of emotional problems related to having type 1 or type 2 diabetes. Previous research has shown that the PAID is a clinically relevant and psychometrically sound instrument [8, 9]. Higher PAID scores were associated with lower levels of adherence to treatment and with higher levels of depression and [10, 11].
The PAID has been translated into several languages and has been validated in Hispanic , Dutch, American , Chinese , Brazilian , Swedish , Icelandic , African American [1, 16] samples. Recently, a 5-item version and a 1-item version of the PAID have been developed . However, because the factor structure of the PAID seems to differ across cultures, further translation and cross-cultural validation of the PAID is needed. In 2002, the prevalence of diabetes in Turkey was estimated at 2.6 million. The aim of the present study is therefore to validate the Turkish version of the PAID and make this instrument available for use in Turkish diabetes research and clinical practices.
2. Participants and Methods
The study was conducted in two outpatient clinics in Istanbul, Turkey: the Istanbul Medical Faculty Hospital and the Cerrahpaşa Medical Faculty Hospital, as described by Makine et al. . A total number of 220 patients with type 2 diabetes mellitus who were treated with diet and/or oral agents were invited to participate in the study. Exclusion criteria for this study were being illiterate or not being able to read due to vision problems. All participants gave written informed consent, and the Ethical Review Committee of the Istanbul University Medical Faculty and Cerrahpaşa Medical Faculty approved the study .
Table 1 shows the sample characteristics of the final 154 participants, separately for the two clinics. Mean age was 56 ± 10 years, mean duration of diabetes was 7 ± 6.5 years, and mean was 6.6 ± 1.0%.
Information was collected on age, sex, marital status, income, education, height, weight, time of diabetes onset, diabetes treatment, complications, and levels. Medical and psychological treatments and history of depression were collected using self-report. As a measure of concurrent validity of the PAID, patients were asked to rate their perception of the difficulty of regulating their diabetes (metabolic control) on a scale from 1 (not difficult) to 4 (very difficult). The Turkish versions of all measures were used.
2.1.1. Diabetes-Specific Emotional Distress (PAID)
The Problem Areas in Diabetes (PAID) scale is a self-report measure with 20 items and was translated by Makine et al. . The items contain statements regarding four domains of quality of life with respect to diabetes (emotional distress, treatment issues, food-related problems, and lack of social support) and are rated on a scale from 0 (not a problem) to 4 (a serious problem). Scores on the PAID are summed and transformed to a 0–100 scale, with higher scores indicating greater emotional distress [8–11].
2.1.2. Depression (CES-D)
The Centre for Epidemiological Studies Depression Scale (CES-D; [19, 20]) was used to assess the occurrence of depressive symptoms in the last week. The CES-D contains 20 items that are rated on a scale from 0 (rarely or never/less than one day) to 3 (most or all the time/5 to 7 days). CES-D scores are summed, with higher scores indicating more depressive symptoms. The internal consistency in this sample was 0.88.
2.1.3. Insulin Treatment Appraisal Scale (ITAS)
The Insulin Treatment Appraisal Scale (ITAS; ) was used to assess attitudes towards insulin treatment . The ITAS contains 20 items that are scored on a scale from 1 (strongly disagree) to 5 (strongly agree). The scores are summed, with a higher score indicating a more negative attitude towards insulin therapy. The internal consistency in this sample was 0.82.
The World Health Organization-Five Well-Being Index (WHO-5; ) was used to assess general emotional well-being. The WHO-5 is a short 5-item measure, rated on a scale from 0 (not at all) to 5 (constantly) how often they have felt in a certain way in the last two weeks. The scores are summed and transformed to a 0–100 scale, with higher scores indicating better emotional well-being. The WHO-5 has an internal consistency of 0.87 in this sample.
2.2. Statistical Analysis
SPSS version 17 for Windows was used to carry out statistical analyses. Associations between categorical variables were analysed using nonparametric tests and continuous variables with t-tests. The Eigenvalue > 1 criterion and inspection of the scree plot  were used to determine the optimal number of factors. To assess the factor structure of the Turkish version of the PAID, exploratory factor analysis with oblimin rotation was used, as we assumed the factors to be correlated. Cronbach’s α was calculated as a measure of internal consistency. To measure concurrent and convergent validity, Pearson product moment correlations, or χ2 for dichotomous variables, were calculated.
3.1. Demographic Indices
Patients from the two clinics did not differ with regard to age, gender, diabetes duration, or treatment. However, the Cerrahpaşa University Hospital had a higher prevalence of depression (CES-D ≥ 16) than the Istanbul University Clinic (19% versus 32%, ρ < 0.05). Furthermore, depression appeared to be more common in women than in men with type 2 diabetes. Moreover, women had a significantly lower education level than men.
Diabetes was treated with diet for 22.7% of the participants, 74,7% of the participants received oral medication and 2,6% of the participants did not receive any treatment yet. Mean value for the Turkish PAID was 27 ± 19.
3.2. Factor Analysis
Using the Kaiser criterion (Eigenvalues > 1), a 1-, 2- or 3-factor solution could be calculated, but as a Dutch-US validation study found four dimensions, we also calculated the 4-factor solution (Table 2). The three- and four-factor solutions resulted in factors with low and double factor loadings. Interestingly, the two-factor solution resulted in a clear 15-item “diabetes distress” factor and a 5-item “support-related issues” factor. The eigenvalue of the diabetes distress factor was 10.4 (explaining 52% of the variance) and the eigenvalue of the support-related issues factor was 1.3 (explaining a further 6.7% of the variance before rotation). The item “feelings of deprivation regarding food” had the highest loading on the diabetes distress factor, and the item “feeling alone with your diabetes” loaded the highest on the support-related issues factor. The internal consistency of the PAID and the two factors were Cronbach’s α = 0.85 for the support-related issues factor, Cronbach’s α = 0.94 for the diabetes distress factor, and Cronbach’s α = 0.95 for the total 20-item PAID.
3.3. Convergent Validity
Table 3 shows the correlations between total 20-item PAID, the two factors and other measures of interest. Also, correlations with the scores on the shorter versions of the PAID, the PAID-1, and PAID-5 are shown as suggested by McGuire et al. . Higher scores on the total PAID and its subscales scores were significantly associated with higher levels of depression (CES-D) scores and a more negative appraisal of insulin therapy (ITAS scores), and also with higher ratings of having problems with the regulation of blood glucose levels. Negative associations were found with WHO-5 scores. Furthermore, older people had lower PAID scores. Additionally, the PAID scores appeared not to be associated with levels or the number of years since diagnosis. The results were comparable for the PAID-1 and PAID-5.
Female participants had significantly higher total PAID scores than males (30 ± 19 versus 23 ± 19; ρ < 0.05), and women also scored slightly higher on both the diabetes distress factor (25 ± 15 versus 20 ± 15, ρ < 0.05) and support-related issues factor (5 ± 5 versus 3 ± 5, ρ < 0.05). Furthermore, a significant association with education was found: participants who attended primary school versus patients that attended college/high school reported higher levels of diabetes-specific emotional distress on the total PAID (35 ± 19 versus 22 ± 17, ρ < 0.05) and on the support-related issues factor (5 ± 5 versus 2 ± 3, ρ < 0.05).
Moreover, patients who reported having complications () scored significantly higher on the PAID total (31 ± 17 versus 24 ± 19, ) and on the diabetes distress factor (27 ± 14 versus 20 ± 16, ρ < 0.05) than patients without complications. Also, patients with a history of depression treatment had significantly higher scores of diabetes distress (31 ± 14 versus 20 ± 15, ρ < 0.01), support-related issues (6 ± 6 versus 4 ± 4, ρ < 0.01), and total PAID scores (37 ± 18 versus 24 ± 17, ρ < 0.01).
The aim of this study was to assess the psychometric properties of the Turkish version of the PAID. Exploratory factor analysis clearly yielded a solution with one general 20-item factor or two separate factors: “diabetes distress” and “support-related issues”. This is only partially consistent with findings from other studies that assessed the cross-cultural validity of the PAID. Factor analyses of the Swedish version of the PAID , consisting of 20 items, found a similar structure although with a three-factor solution: diabetes-related emotional problems, treatment-related problems, and also a support-related problems scale. Also, even though the factor solution in an Icelandic sample  resulted in two similarly named factors: “distress in relation to life with diabetes” and “distress in relation to management of diabetes”, they are not comparable to the factors found in this study.
In Dutch and US diabetes patients however, Snoek et al.  reported that both a one- and a four-factor solution (emotional, treatment, food, and lack of support problems) fitted well. Also, the Chinese version consisted of only one factor . In short, even though the twenty item scales are comparable between countries, the subscales are not. Consequently, the comparability of study results from different countries is perhaps rather low in case subscales are being used.
The Turkish version of the PAID and its two factors appeared to be internally consistent. As expected, the PAID and the two factors were strongly associated with generic measures of affect. Higher levels of diabetes distress were associated with a higher frequency of depressive symptoms occurrence, negative attitudes toward insulin treatment, difficulties with the regulation of the blood glucose, and lower levels of emotional well-being. Additionally, patients who reported having diabetes complications or a history of depression treatment scored significantly higher on the PAID, indicative of discriminative validity. Furthermore, PAID scores were unrelated to the number of years since diagnosis. Unexpectedly, and incongruent with other studies, the PAID was not related to levels [8, 10, 11, 14, 15]. However, the patients included in the sample were insulin naïve and well controlled with respect to . The absence of poorly controlled patients in the present sample may thus explain why diabetes-specific emotional distress was not associated with glycemic control. A non significant association between PAID and was also found in a Brazilian sample ()  and two African American samples ( and ) [1, 16]. These non significant associations may be explained by the small samples sizes of these studies. Additionally, an unexpected effect of education level on PAID scores was found, inconsistent with other studies [8–11] but in concurrence with some other studies [1, 13, 15]. The relationship between higher education and lower PAID scores may be explained by an increased understanding of knowledge, diabetes control, and diabetes care for patients with higher education .
Other studies have found a distress factor similar to the one in the current study. Interestingly, “worry about the future and the possibility of serious complications” was consistently found to be the emotional problem with the highest factor loading [8, 10, 11, 14, 16] whereas in the present study “feelings of deprivation regarding food” was the item with the highest loading. Furthermore, where a special “food-related problems” factor was found in the Dutch and US sample , in the current study, the items regarding food did not form a separate factor but instead were strongly integrated in the diabetes distress factor. These findings suggest cross-cultural differences in diabetes-related distress. Where in countries such as the Netherlands and the United States food issues are seen as related to diabetes but separate from social problems , it may be that in countries such as Turkey food is an integral and important factor of social life. A limitation of the study was that the sample was too small to allow confirmatory factor analysis, which could have provided with confirmatory evidence of the factor solution found in the current study. Furthermore, the test-retest reliability of the Turkish version was not assessed.
In conclusion, the Turkish version of the PAID showed good internal consistency, discriminative, and convergent validity, but appeared to have a different factor structure than other versions. For international comparisons, use of the 20-item overall factor solution is recommended.
|PAID:||Problem Areas In Diabetes survey|
|BMI:||Body mass index|
The authors wish to express their gratitude to the patients who participated in the present study. This study was supported by an unrestricted grant from Novo Nordisk Turkey and Novo Nordisk Denmark. All the authors are members at the European Depression in Diabetes (EDID) Research Consortium.
- M. S. Spencer, E. C. Kieffer, B. R. Sinco et al., “Diabetes-specific emotional distress among African Americans and hispanics with type 2 diabetes,” Journal of Health Care for the Poor and Underserved, vol. 17, no. 2, pp. 88–105, 2006.
- S. Ali, M. A. Stone, J. L. Peters, M. J. Davies, and K. Khunti, “The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis,” Diabetic Medicine, vol. 23, no. 11, pp. 1165–1173, 2006.
- A. Kokoszka, F. Pouwer, A. Jodko et al., “Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: a polish study from the European depression in diabetes (EDID) research consortium,” European Psychiatry, vol. 24, no. 7, pp. 425–430, 2009.
- F. Pouwer, T. C. Skinner, M. Pibernik-Okanovic et al., “Serious diabetes-specific emotional problems and depression in a croatian-Dutch-English survey from the European depression in diabetes [EDID] research consortium,” Diabetes Research and Clinical Practice, vol. 70, no. 2, pp. 166–173, 2005.
- T. L. Albright, M. Parchman, and S. K. Burge, “Predictors of self-care behavior in adults with type 2 diabetes: an RRNeST study,” Family Medicine, vol. 33, no. 5, pp. 354–360, 2001.
- M. Peyrot, R. R. Rubin, T. Lauritzen, F. J. Snoek, D. R. Matthews, and S. E. Skovlund, “Psychosocial problems and barriers to improved diabetes management: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study,” Diabetic Medicine, vol. 22, no. 10, pp. 1379–1385, 2005.
- F. Pouwer, A. T. Beekman, C. Lubach, and F. J. Snoek, “Nurses' recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus,” Patient Education and Counseling, vol. 60, no. 2, pp. 235–240, 2006.
- F. J. Snoek, F. Pouwer, G. W. Welch, and W. H. Polonsky, “Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale,” Diabetes Care, vol. 23, no. 9, pp. 1305–1309, 2000.
- G. Welch, K. Weinger, B. Anderson, and W. H. Polonsky, “Responsiveness of the problem areas in diabetes (PAID) questionnaire,” Diabetic Medicine, vol. 20, no. 1, pp. 69–72, 2003.
- W. H. Polonsky, B. J. Anderson, P. A. Lohrer et al., “Assessment of diabetes-related distress,” Diabetes Care, vol. 18, no. 6, pp. 754–760, 1995.
- G. W. Welch, A. M. Jacobson, and W. H. Polonsky, “The problem areas in diabetes scale: an evaluation of its clinical utility,” Diabetes Care, vol. 20, no. 5, pp. 760–766, 1997.
- M. F. Huang, M. Courtney, H. Edwards, and J. McDowell, “Validation of the Chinese version of the problem areas in diabetes (PAID-C) scale,” Diabetes Care, vol. 33, no. 1, pp. 38–40, 2010.
- C. C. Gross, S. F. Scain, R. Scheffel, J. L. Gross, and C. S. Hutz, “Brazilian version of the problem areas in diabetes scale (B-PAID): validation and identification of individuals at high risk for emotional distress,” Diabetes Research and Clinical Practice, vol. 76, no. 3, pp. 455–459, 2007.
- S. Amsberg, R. Wredling, P. E. Lins, U. Adamson, and U. B. Johansson, “The psychometric properties of the Swedish version of the problem areas in diabetes scale (Swe-PAID-20): scale development,” International Journal of Nursing Studies, vol. 45, no. 9, pp. 1319–1328, 2008.
- A. K. Sigurdardottir and R. Benediktsson, “Reliability and validity of the Icelandic version of the problem area in diabetes (PAID) scale,” International Journal of Nursing Studies, vol. 45, no. 4, pp. 526–533, 2008.
- S. T. Miller and T. A. Elasy, “Psychometric evaluation of the problem areas in diabetes (PAID) survey in Southern, rural African American women with type 2 diabetes,” BMC Public Health, vol. 8, article 70, 2008.
- B. E. McGuire, T. G. Morrison, N. Hermanns et al., “Short-form measures of diabetes-related emotional distress: the problem areas in diabetes scale (PAID)-5 and PAID-1,” Diabetologia, vol. 53, no. 1, pp. 66–69, 2010.
- C. Makine, C. Karsidag, P. Kadioglu et al., “Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with type 2 diabetes mellitus. a study from the European depression in diabetes [EDID] research consortium,” Diabetic Medicine, vol. 26, no. 1, pp. 28–33, 2009.
- J. Spijker, F. B. Van der Wurff, E. C. Poort, C. H. M. Smits, A. P. Verhoeff, and A. T. F. Beekman, “Depression in first generation labour migrants in Western Europe: the utility of the center for epidemiologic studies depression scale (CES-D),” International Journal of Geriatric Psychiatry, vol. 19, no. 6, pp. 538–544, 2004.
- F. B. Van Der Wurff, A. T. F. Beekman, H. Dijkshoorn et al., “Prevalence and risk-factors for depression in elderly Turkish and Moroccan migrants in the Netherlands,” Journal of Affective Disorders, vol. 83, no. 1, pp. 33–41, 2004.
- F. J. Snoek, S. E. Skovlund, and F. Pouwer, “Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes,” Health and Quality of Life Outcomes, vol. 5, article 69, 2007.
- M. de Wit, F. Pouwer, R. J. B. J. Gemke, H. A. Delemarre-van de Waal, and F. J. Snoek, “Validation of the WHO-5 well-being index in adolescents with type 1 diabetes,” Diabetes Care, vol. 30, no. 8, pp. 2003–2006, 2007.
- R. B. Cattell, “The scree test for the number of factors,” Multivariate Behavioral Research, vol. 1, no. 2, pp. 245–276, 1966.
- M. Heisler, J. D. Piette, M. Spencer, E. Kieffer, and S. Vijan, “The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management,” Diabetes Care, vol. 28, no. 4, pp. 816–822, 2005.